Michael F. Press, MD, PhD - Challenging Cases in HER2 Testing
(Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - June 26, 2013 Category: Cancer & Oncology Authors: Answers in CME Tags: Science, Medicine Source Type: podcasts
Michael F. Press, MD, PhD - Best Practices in HER2 Testing for Breast Cancer
(Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - May 31, 2013 Category: Cancer & Oncology Authors: Answers in CME Tags: Science, Medicine Source Type: podcasts
T-DM1 and the Dawn of Precision Medicine
Dr. Maurie Markman sees T-DM1, which combines antitumor activities of trastuzumab and HER2-targeted delivery of a cytotoxic agent, as an example of the precision medicine we can expect in the future. (Source: Medscape Pathology and Laboratory Medicine Podcast)
Source: Medscape Pathology and Laboratory Medicine Podcast - March 20, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts
HER2 Clinical Trials and Their Use in Upper Gastrointestinal Cancers
Dr. Johanna Bendell talks about the HER2 Clinical Trials and Their Use in Upper Gastrointestinal Cancers at the ASCO GI meeting 2013
Author: imedex
Added: 02/05/2013 (Source: Oncology Tube)
Source: Oncology Tube - February 6, 2013 Category: Cancer & Oncology Source Type: podcasts
New CAP/ASCO Recommendations for ER/PgR and HER2 Testing in Breast Cancer
Breast cancer is the most common cancer in American women, with more than 200,000 new cases diagnosed in 2010. (Source: NewsPath Podcasts)
Source: NewsPath Podcasts - October 4, 2012 Category: Pathology Authors: Julie Katz Karp, MD Source Type: podcasts
The Lancet: January 29, 2010
Discussion of herceptin and chemotherapy for early advanced HER2+ breast cancer. (Source: Listen to The Lancet)
Source: Listen to The Lancet - January 29, 2010 Category: General Medicine Authors: The Lancet Source Type: podcasts
